The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Beyfortus (nirsevimab) to treat respiratory syncytial virus (RSV) lower respiratory tract disease in the infants and newborns during their first RSV season. This approval come after the European Commission approve Beyfortus earlier this month. According to studies, about 90 percent of children by 2 […]
Continue Reading
The United States will keep the COVID-19 Public Health Emergency status of the pandemic in place, allowing millions of US citizens to get free COVID-19 tests, treatments, and vaccines until April 2023, say US government officials. The US population may be in the middle of a COVID-19 surge in January 2023, and this is not […]
Continue Reading
After losing the approval for emergency use of COVID-19 vaccines, AstraZeneca has finally stopped efforts to sell its COVID-19 vaccine shots in the United States. AstraZeneca has now decided to withdraw its application for the COVID-19 vaccine Vaxzevria with the US FDA, said CEO Pascal Soriot during a press briefing. Because the US FDA has […]
Continue Reading
Oncopeptides AB, a biotech company focused on R&D of development of therapies to treat haematological diseases, announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for Pepaxti in combination with dexamethasone in the United Kingdom. The approval of Pepaxti in the United Kingdom is an important milestone for the […]
Continue Reading
The US Food and Drug Administration (FDA) approved AstraZeneca’s cancer drugs Imfinzi and Imjudo in combination with chemotherapy to treat patients with stage 4 non-small cell lung cancer. This approval is based on the phase 3 data published in September 2021. Imfinzi and Imjudo with chemotherapy have shown an overall 23 percent improvement in patients […]
Continue Reading
The US Centers for Disease Control and Prevention (CDC) are investigating the cause of the listeria outbreak across six states in the United States. The US CDC has issued an advisory for the people who consume Deli meat, including lunch meats, cold cuts, and hot dogs. The older individuals above 65 years, pregnant women, and […]
Continue Reading
The US Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended AstraZeneca’s PT027 for the treatment of asthma in people aged 18 years and older. The Committee has voted 9 to 8 for adolescents aged 12 to 17 years, and the data do not support a favourable risk assessment for the use […]
Continue Reading
The UK Medicines and Healthcare Products Regulatory Agency (MHRA), has approved Nuvaxovid, COVID-19 vaccine developed by Novavax, as a vaccine booster for 12 years to 17 years old children. The approval follows a review of the safety, effectiveness, and quality of the COVID-19 vaccine in the age group, and expert advice from the Commission on […]
Continue Reading
Using cutting-edge genome sequencing techniques, researchers at the Indian Institute of Technology (IIT), Jodhpur, have discovered variants in the COVID-19 virus’s RNA, according to officials. The fixation of these intra-host variations and mutations that results in variants have both been researched by experts. The journal “Nucleic Acid Research” has published the findings of the two-phase […]
Continue Reading
According to a new study, Moderna’s COVDI-19 vaccine, Spikevax, has a higher risk of heart inflammation associated with products from Pfizer and BioNTech. The study, published in the Journal of the American College of Cardiology, concluded that the risk of myocarditis is much higher after a second dose of Moderna’s Spikevax compared with Comirnaty from […]
Continue Reading